News

Filter

Current filters:

None

62 to 71 of 97859 results

FDA accepts for review Synageva's Biologics License Application for Kanuma

FDA accepts for review Synageva's Biologics License Application for Kanuma

23-02-2015

The US Food and Drug Administration has accepted for review the Biologics License Application for Kanuma…

BiotechnologyGeneticsKanumaRegulationSynageva BioPharmaUSA

Cyclenium signs drug discovery and collaboration agreement with Fundación MEDINA

Cyclenium signs drug discovery and collaboration agreement with Fundación MEDINA

23-02-2015

Emerging pharma company Cyclenium, focused on proprietary macrocyclic chemistry, has signed a drug discovery…

Antibiotics and Infectious diseasesBiotechnologyCycleniumFundacion MEDINAResearchSpain

Sosei acquires Heptares Therapeutics for up to $400 million

Sosei acquires Heptares Therapeutics for up to $400 million

23-02-2015

Japanese drugmaker Sosei Group says it has acquired Heptares Therapeutics, a clinical-stage private UK-based…

BiotechnologyHeptares TherapeuticsMergers & AcquisitionsNeurologicalRare diseasesSosei

Valeant fourth-qtr 2014 earnings beat expectations

Valeant fourth-qtr 2014 earnings beat expectations

23-02-2015

Canada’s Valeant Pharmaceutical International posted financial results late Sunday, showing that fourth-quarter…

FinancialPharmaceuticalValeantValeant Pharmaceutical InternationalValeant Pharmaceuticals International

Roche likely to lose another state contract in Russia

Roche likely to lose another state contract in Russia

23-02-2015

Swiss pharma giant Roche will probably lose one of its major contracts in Russia for the next several…

AvastinBiocadBiosimilarsBiotechnologyMarkets & MarketingOncologyRocheRussia

Almirall reports strong 2014 financial results following AstraZeneca transfer

Almirall reports strong 2014 financial results following AstraZeneca transfer

23-02-2015

Almirall, Spain’s largest drugmaker, has continued its upward trend and reported strong results for…

AlmirallEkliraFinancialPharmaceuticalSativexSpain

Dupilumab Phase IIb shows improvement in patient-reported outcomes for dermatitis

Dupilumab Phase IIb shows improvement in patient-reported outcomes for dermatitis

23-02-2015

A Phase IIb study of dupilumab, from Sanofi and Regeneron, has shown that the drug improved patient-reported…

DermatologicalsdupilumabPharmaceuticalRegeneronResearchSanofi

Report: Cutting pharmacies in Russia could benefit patients

23-02-2015

A reduction in the number of pharmacies in Russia could lead to cheaper drug prices for patients, according…

KazakhstanMarkets & MarketingMedicinal chemistryPharmaceuticalPharmacistRussiaUkraine

Opportunities, challenges, strategies and forecasts for generic drugs market; report

Opportunities, challenges, strategies and forecasts for generic drugs market; report

23-02-2015

Already prevalent in the USA, Europe and much of the developing world, generic drugs are now finding…

BiosimilarsEuropeGenericsGlobalMarkets & Marketing

62 to 71 of 97859 results

COMPANY SPOTLIGHT

Menarini

Back to top